359 related articles for article (PubMed ID: 16536633)
1. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
Coats AJ
Drugs Aging; 2006; 23(2):93-9. PubMed ID: 16536633
[TBL] [Abstract][Full Text] [Related]
2. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
3. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
Moen MD; Wagstaff AJ
Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
[TBL] [Abstract][Full Text] [Related]
4. beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.
Dobre D; Haaijer-Ruskamp FM; Voors AA; van Veldhuisen DJ
Drugs Aging; 2007; 24(12):1031-44. PubMed ID: 18020535
[TBL] [Abstract][Full Text] [Related]
5. The effects of newer beta-adrenoceptor antagonists on vascular function in cardiovascular disease.
Wehland M; Grosse J; Simonsen U; Infanger M; Bauer J; Grimm D
Curr Vasc Pharmacol; 2012 May; 10(3):378-90. PubMed ID: 22022769
[TBL] [Abstract][Full Text] [Related]
6. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.
Del Sindaco D; Tinti MD; Monzo L; Pulignano G
Clin Interv Aging; 2010 Dec; 5():381-93. PubMed ID: 21152240
[TBL] [Abstract][Full Text] [Related]
9. Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients.
Marazzi G; Volterrani M; Caminiti G; Iaia L; Massaro R; Vitale C; Sposato B; Mercuro G; Rosano G
J Card Fail; 2011 Sep; 17(9):703-9. PubMed ID: 21872138
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers in heart failure. The 'new wave' of clinical trials.
Krum H
Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol for heart failure in the elderly.
Tavazzi L
Expert Rev Cardiovasc Ther; 2007 May; 5(3):423-33. PubMed ID: 17489667
[TBL] [Abstract][Full Text] [Related]
12. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol for the treatment of heart failure.
Riva N; Lip GY
Expert Opin Investig Drugs; 2011 Dec; 20(12):1733-46. PubMed ID: 21980961
[TBL] [Abstract][Full Text] [Related]
14. Nebivolol: third-generation beta-blockade.
de Boer RA; Voors AA; van Veldhuisen DJ
Expert Opin Pharmacother; 2007 Jul; 8(10):1539-50. PubMed ID: 17661735
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Whorlow SL; Krum H
Am J Cardiol; 2000 Oct; 86(8):886-9. PubMed ID: 11024409
[No Abstract] [Full Text] [Related]
16. The effect of beta-blockers on the adaptive immune system in chronic heart failure.
Shaw SM; Coppinger T; Waywell C; Dunne L; Archer LD; Critchley WR; Yonan N; Fildes JE; Williams SG
Cardiovasc Ther; 2009; 27(3):181-6. PubMed ID: 19689617
[TBL] [Abstract][Full Text] [Related]
17. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.
Ghio S; Magrini G; Serio A; Klersy C; Fucili A; Ronaszèki A; Karpati P; Mordenti G; Capriati A; Poole-Wilson PA; Tavazzi L;
Eur Heart J; 2006 Mar; 27(5):562-8. PubMed ID: 16443607
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol: a review of its use in chronic heart failure.
Keating GM; Jarvis B
Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
[TBL] [Abstract][Full Text] [Related]
19. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Wikstrand J; Wedel H; Castagno D; McMurray JJ
J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
[TBL] [Abstract][Full Text] [Related]
20. Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
Shibata MC; Flather MD; Böhm M; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Parkhomenko A; Soler-Soler J; Tavazzi L; Toman J; Van Veldhuisen DJ; Coats AJ; Poole-Wilson P;
Int J Cardiol; 2002 Nov; 86(1):77-85. PubMed ID: 12243852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
